{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:28:31Z","timestamp":1793384911439,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12325-025-03289-2","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:59:16Z","timestamp":1753261156000},"page":"4571-4582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the Compositional Quality of Probiotics Containing Bacillus clausii in India"],"prefix":"10.1007","volume":"42","author":[{"given":"Dhanasekhar","family":"Kesavelu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Ganpathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Jog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaswati","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Telang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"3289_CR1","doi-asserted-by":"publisher","first-page":"1018594","DOI":"10.3389\/fmicb.2022.1018594","volume":"13","author":"Z Huang","year":"2022","unstructured":"Huang Z, Liu K, Ma W, Li D, Mo T, Liu Q. The gut microbiome in human health and disease-where are we and where are we going? Bibliometr Anal Front Microbiol. 2022;13:1018594.","journal-title":"Bibliometr Anal Front Microbiol"},{"issue":"11","key":"3289_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823\u201336.","journal-title":"Biochem J"},{"issue":"5","key":"3289_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","volume":"22","author":"AK DeGruttola","year":"2016","unstructured":"DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137\u201350.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"3289_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","volume":"17","author":"M Levy","year":"2017","unstructured":"Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3289_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/microorganisms10030578","volume":"10","author":"T Hrncir","year":"2022","unstructured":"Hrncir T. Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022;10(3):578.","journal-title":"Microorganisms"},{"key":"3289_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.625210","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Xia S, Jiang X, et al. gut microbiota and diarrhea: an updated review. Front Cell Infect Microbiol. 2021;11:625210.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"3289_CR7","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.3390\/nu6125786","volume":"6","author":"S Schippa","year":"2014","unstructured":"Schippa S, Conte MP. Dysbiotic events in gut microbiota: impact on human health. Nutrients. 2014;6(12):5786\u2013805.","journal-title":"Nutrients"},{"key":"3289_CR8","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.pedn.2022.06.005","volume":"66","author":"H Arifin","year":"2022","unstructured":"Arifin H, Rakhmawati W, Kurniawati Y, et al. Prevalence and determinants of diarrhea among under-five children in five Southeast Asian countries: evidence from the demographic health survey. J Pediatr Nurs. 2022;66:e37\u201345.","journal-title":"J Pediatr Nurs"},{"issue":"1","key":"3289_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12887-023-04073-3","volume":"23","author":"K Ghosh","year":"2023","unstructured":"Ghosh K, Chakraborty AS, SenGupta S. Identifying spatial clustering of diarrhoea among children under 5\u00a0years across 707 districts in India: a cross sectional study. BMC Pediatr. 2023;23(1):272.","journal-title":"BMC Pediatr"},{"key":"3289_CR10","unstructured":"World Health Organization. Diarrhoeal disease 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diarrhoeal-disease. Accessed on 31 January 2025."},{"issue":"8","key":"3289_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506\u201314.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"3289_CR12","volume":"12","author":"D Kesavelu Sr","year":"2020","unstructured":"Kesavelu D Sr, Rohit A, Karunasagar I, Karunasagar I. Composition and laboratory correlation of commercial probiotics in India. Cureus. 2020;12(11):e11334.","journal-title":"Cureus"},{"issue":"1","key":"3289_CR13","doi-asserted-by":"publisher","first-page":"2185034","DOI":"10.1080\/19490976.2023.2185034","volume":"15","author":"D Merenstein","year":"2023","unstructured":"Merenstein D, Pot B, Leyer G, et al. Emerging issues in probiotic safety: 2023 perspectives. Gut Microbes. 2023;15(1):2185034.","journal-title":"Gut Microbes"},{"issue":"2","key":"3289_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MPG.0000000000003633","volume":"76","author":"H Szajewska","year":"2023","unstructured":"Szajewska H, Berni Canani R, Domell\u00f6f M, et al. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications. J Pediatr Gastroenterol Nutr. 2023;76(2):232\u201347.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"3289_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s13312-022-2557-7","volume":"59","author":"SK Yachha","year":"2022","unstructured":"Yachha SK, Sarma MS, Mohan N, et al. Indian academy of pediatrics consensus guidelines for probiotic use in childhood diarrhea. Indian Pediatr. 2022;59(7):543\u201351.","journal-title":"Indian Pediatr"},{"key":"3289_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12979-015-0051-y","volume":"12","author":"M Lefevre","year":"2015","unstructured":"Lefevre M, Racedo SM, Ripert G, et al. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun Ageing. 2015;12:24.","journal-title":"Immun Ageing"},{"issue":"10","key":"3289_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/nu9101156","volume":"9","author":"A Llewellyn","year":"2017","unstructured":"Llewellyn A, Foey A. Probiotic modulation of innate cell pathogen sensing and signaling events. Nutrients. 2017;9(10):1156.","journal-title":"Nutrients"},{"issue":"2","key":"3289_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4161\/gmic.2.2.15661","volume":"2","author":"K Shida","year":"2011","unstructured":"Shida K, Nanno M, Nagata S. Flexible cytokine production by macrophages and T\u00a0cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes. 2011;2(2):109\u201314.","journal-title":"Gut Microbes"},{"issue":"6","key":"3289_CR19","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3390\/microorganisms10061246","volume":"10","author":"E Ghelardi","year":"2022","unstructured":"Ghelardi E, Abreu YAAT, Marzet CB, \u00c1lvarez Calatayud G, Perez M 3rd, Moschione Castro AP. Current progress and future perspectives on the use of Bacillus clausii. Microorganisms. 2022;10(6):1246.","journal-title":"Microorganisms"},{"issue":"4","key":"3289_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40121-020-00333-2","volume":"9","author":"M Plomer","year":"2020","unstructured":"Plomer M, Iii Perez M, Greifenberg DM. Effect of Bacillus clausii capsules in reducing adverse effects associated with Helicobacter pylori eradication therapy: a randomized, double-blind. Controll Trial Infect Dis Ther. 2020;9(4):867\u201378.","journal-title":"Controll Trial Infect Dis Ther"},{"issue":"2","key":"3289_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3920\/BM2012.0034","volume":"4","author":"MR Sudha","year":"2013","unstructured":"Sudha MR, Bhonagiri S, Kumar MA. Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea. Benef Microbes. 2013;4(2):211\u20136.","journal-title":"Benef Microbes"},{"issue":"1","key":"3289_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12866-022-02631-w","volume":"22","author":"A Kharwar","year":"2022","unstructured":"Kharwar A, Bazaz MR, Dandekar MP. Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus clausii spores. BMC Microbiol. 2022;22(1):217.","journal-title":"BMC Microbiol"},{"issue":"8","key":"3289_CR23","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/nu10081074","volume":"10","author":"G Ianiro","year":"2018","unstructured":"Ianiro G, Rizzatti G, Plomer M, et al. Bacillus clausii for the treatment of acute diarrhea in children: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2018;10(8):1074.","journal-title":"Nutrients"},{"key":"3289_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.toxrep.2016.12.004","volume":"4","author":"SG Lakshmi","year":"2017","unstructured":"Lakshmi SG, Jayanthi N, Saravanan M, Ratna MS. Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic. Toxicol Rep. 2017;4:62\u201371.","journal-title":"Toxicol Rep"},{"issue":"1","key":"3289_CR25","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1038\/s41598-024-56627-9","volume":"14","author":"HT Dang","year":"2024","unstructured":"Dang HT, Tran DM, Phung TTB, et al. Promising clinical and immunological efficacy of Bacillus clausii spore probiotics for supportive treatment of persistent diarrhea in children. Sci Rep. 2024;14(1):6422.","journal-title":"Sci Rep"},{"key":"3289_CR26","first-page":"204993612311544","volume":"10","author":"D Kesavelu","year":"2023","unstructured":"Kesavelu D, Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis. 2023;10:20499361231154444.","journal-title":"Ther Adv Infect Dis"},{"key":"3289_CR27","doi-asserted-by":"crossref","unstructured":"Michel MC, Pellegrino P. A comprehensive review and meta-analysis on the treatment of acute gastroenteritis in children with a Bacillus clausii preparation (Enterogermina(\u00ae)). Adv Ther. 2025;42(7):3076\u201388.","DOI":"10.1007\/s12325-025-03221-8"},{"issue":"2","key":"3289_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.fm.2010.03.007","volume":"28","author":"SM Cutting","year":"2011","unstructured":"Cutting SM. Bacillus probiotics. Food Microbiol. 2011;28(2):214\u201320.","journal-title":"Food Microbiol"},{"key":"3289_CR29","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3389\/fmicb.2017.01490","volume":"8","author":"FMF Elshaghabee","year":"2017","unstructured":"Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol. 2017;8:1490.","journal-title":"Front Microbiol"},{"issue":"1","key":"3289_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12866-019-1680-7","volume":"19","author":"I Khatri","year":"2019","unstructured":"Khatri I, Sharma G, Subramanian S. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina(\u00ae), and insights into its probiotic properties. BMC Microbiol. 2019;19(1):307.","journal-title":"BMC Microbiol"},{"issue":"1","key":"3289_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/MPG.0000000000001603","volume":"65","author":"S Kola\u010dek","year":"2017","unstructured":"Kola\u010dek S, Hojsak I, Berni Canani R, et al. Commercial probiotic products: a call for improved quality control. A position paper by the ESPGHAN working group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr. 2017;65(1):117\u201324.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3289_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2478\/cipms-2019-0022","volume":"32","author":"I Korona-Glowniak","year":"2019","unstructured":"Korona-Glowniak I, Siwiec R, Luszczewska-Sierakowska I, Maciejewski R, Wrobel R, Malm A. Microbiological evaluation of 10 commercial probiotic products available in Poland. Curr Issues Pharmacy Med Sci. 2019;32:121\u20134.","journal-title":"Curr Issues Pharmacy Med Sci"},{"key":"3289_CR33","doi-asserted-by":"publisher","first-page":"1216674","DOI":"10.3389\/fmicb.2023.1216674","volume":"14","author":"A Latif","year":"2023","unstructured":"Latif A, Shehzad A, Niazi S, et al. Probiotics: mechanism of action, health benefits and their application in food industries. Front Microbiol. 2023;14:1216674.","journal-title":"Front Microbiol"},{"key":"3289_CR34","unstructured":"Indian Council of Medical Research Task Force, Co-ordinating Unit ICMR, Co-ordinating Unit DBT. ICMR-DBT guidelines for evaluation of probiotics in food. Indian J Med Res. 2011;134(1):22-5."},{"issue":"6","key":"3289_CR35","first-page":"155","volume":"64","author":"S Vallabhaneni","year":"2015","unstructured":"Vallabhaneni S, Walker TA, Lockhart SR, et al. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement\u2013Connecticut, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(6):155\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3289_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.693973","volume":"12","author":"D Mazzantini","year":"2021","unstructured":"Mazzantini D, Calvigioni M, Celandroni F, Lupetti A, Ghelardi E. Spotlight on the compositional quality of probiotic formulations marketed worldwide. Front Microbiol. 2021;12:693973.","journal-title":"Front Microbiol"},{"issue":"2","key":"3289_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0944-5013(97)80009-2","volume":"152","author":"F Canganella","year":"1997","unstructured":"Canganella F, Paganini S, Ovidi M, et al. A microbiological investigation on probiotic pharmaceutical products used for human health. Microbiol Res. 1997;152(2):171\u20139.","journal-title":"Microbiol Res"},{"issue":"2","key":"3289_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijfoodmicro.2004.04.015","volume":"97","author":"V Coeuret","year":"2004","unstructured":"Coeuret V, Gueguen M, Vernoux JP. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol. 2004;97(2):147\u201356.","journal-title":"Int J Food Microbiol"},{"issue":"5","key":"3289_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1179\/joc.2004.16.5.436","volume":"16","author":"L Drago","year":"2004","unstructured":"Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR. Microbiological evaluation of commercial probiotic products available in Italy. J Chemother. 2004;16(5):463\u20137.","journal-title":"J Chemother"},{"issue":"6","key":"3289_CR40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10620-005-2714-6","volume":"50","author":"J Drisko","year":"2005","unstructured":"Drisko J, Bischoff B, Giles C, Adelson M, Rao RV, McCallum R. Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis. Dig Dis Sci. 2005;50(6):1113\u20137.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3289_CR41","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/13102818.2019.1621208","volume":"33","author":"VY Marinova","year":"2019","unstructured":"Marinova VY, Rasheva IK, Kizheva YK, Dermenzhieva YD, Hristova PK. Microbiological quality of probiotic dietary supplements. Biotechnol Biotechnol Equip. 2019;33(1):834\u201341.","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"7","key":"3289_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/microorganisms7070188","volume":"7","author":"M Ullah","year":"2019","unstructured":"Ullah M, Raza A, Ye L, Yu Z. Viability and composition validation of commercial probiotic products by selective culturing combined with next-generation sequencing. Microorganisms. 2019;7(7):188.","journal-title":"Microorganisms"},{"key":"3289_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fmed.2018.00059","volume":"5","author":"A Vecchione","year":"2018","unstructured":"Vecchione A, Celandroni F, Mazzantini D, Senesi S, Lupetti A, Ghelardi E. Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy. Front Med. 2018;5:59.","journal-title":"Front Med"},{"key":"3289_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijfoodmicro.2016.08.012","volume":"237","author":"V Patrone","year":"2016","unstructured":"Patrone V, Molinari P, Morelli L. Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan. Int J Food Microbiol. 2016;237:92\u20137.","journal-title":"Int J Food Microbiol"},{"issue":"2","key":"3289_CR45","first-page":"121","volume":"94","author":"E Elliot","year":"2004","unstructured":"Elliot E, Teversham K. An evaluation of nine probiotics available in South Africa, August 2003. S Afr Med J. 2004;94(2):121\u20134.","journal-title":"S Afr Med J"},{"issue":"1","key":"3289_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-1605(02)00162-9","volume":"81","author":"R Temmerman","year":"2003","unstructured":"Temmerman R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol. 2003;81(1):1\u201310.","journal-title":"Int J Food Microbiol"},{"key":"3289_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.18535\/jmscr\/v12i06.04","volume":"12","author":"R Rajeshkumar","year":"2024","unstructured":"Rajeshkumar R. A comparative evaluation of Bifilac clausi vs enterogermina and other selected brands for probiosimilarity. J Med Sci Clin Res. 2024;12:19\u201328.","journal-title":"J Med Sci Clin Res"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03289-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03289-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03289-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:08:28Z","timestamp":1772446108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03289-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3289"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03289-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor\u2019s Note: Readers are alerted that this article is currently under investigation as concerns have been raised regarding a potential undisclosed conflict of interest. Appropriate editorial action will be taken once this matter is resolved.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sridhar Ganpathy has received speaking honoraria from Opella. Dhanasekhar Kesavelu, Pramod Jog, Bhaswati Acharya, and Vivek Saxena have nothing to disclose. Nilesh Gaikwad and Nivedita Telang are employees of Opella and may hold shares and\/or stock options in the company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study did not involve human participants, animal subjects, or any sensitive personal data; therefore, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}